Keywords: watson, pays, 178m, novartis, headache, drugs, pharmaceuticals

Watson pays $178M for Novartis headache drugs

Article | 27 January 2003

Print This

Watson Pharmaceuticals has said it will pay $178 million for the USrights to two product lines sold by Novartis for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in